Sofwave Medical reported accelerating Q2 2026 revenue and highlighted strong demand for its ultrasonic microneedling platform, positioning the company as a beneficiary of the shift toward energy-based modalities for skin tightening and collagen remodeling. The company disclosed both second-quarter and first-half 2026 financial results alongside business highlights, signaling confidence in the ultrasonic category's trajectory.